or Try an Advanced Search...

    Technical Analysis for RKV - Rakovina Therapeutics Inc

    Grade Last Price % Change Price Change
    F 0.080 -5.88% -0.005
    RKV closed unchanged on Monday, September 9, 2024, on approximately normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical RKV trend table...
    Date Alert Name Type % Chg
    Gapped Up Strength -5.88%
    Volume Surge Other -5.88%
    Lower Bollinger Band Touch Weakness -5.88%
    Fell Below 20 DMA Bearish -11.11%
    Fell Below 200 DMA Bearish -11.11%
    MACD Bearish Signal Line Cross Bearish -11.11%
    Calm After Storm Range Contraction -11.11%
    Narrow Range Bar Range Contraction -11.11%
    Inside Day Range Contraction -11.11%
    Gapped Down Weakness -11.11%
    Older End-of-Day Signals for RKV ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 1 hour ago
    Down 5% about 1 hour ago
    Down 3% about 1 hour ago
    Down 2% about 1 hour ago
    Down 1% about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RKV Chart by TradingView
    Basic chart:

    Profile

    Rakovina Therapeutics, Inc., formerly Vincero Capital Corp., is a Canada-based company, which is engaged in developing cancer treatments based on DNA-damage response technologies. The Company’s lead product candidate is kt-2000 Next Generation PARP-inhibitors. Its pipeline includes kt-3000 Dual Action DDR-inhibitors and kt-4000 DNA Damaging DDR-inhibitors. Its kt-2000 series is a patented class of highly potent, oral inhibitors of poly (ADP-ribose) polymerase (PARP). Its kt-3000 drug candidates selectively inhibit secondary DDR pathways associated with treatment resistance and PARP. kt-4000 drug candidates release a potent DNA-damaging agent, while also inhibiting DDR to selectively kill cancer cells.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Catalysts

    Is RKV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.16
    52 Week Low 0.005
    Average Volume 32,069
    200-Day Moving Average 0.091
    50-Day Moving Average 0.098
    20-Day Moving Average 0.092
    10-Day Moving Average 0.091
    Average True Range 0.007
    RSI (14) 44.44
    ADX 35.3
    +DI 11.133
    -DI 29.722
    Chandelier Exit (Long, 3 ATRs) 0.083
    Chandelier Exit (Short, 3 ATRs) 0.102
    Upper Bollinger Bands 0.101
    Lower Bollinger Band 0.083
    Percent B (%b) 0.09
    BandWidth 18.696
    MACD Line -0.003
    MACD Signal Line -0.002
    MACD Histogram -0.0005
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.093
    Resistance 3 (R3) 0.093 0.092 0.091
    Resistance 2 (R2) 0.092 0.090 0.091 0.091
    Resistance 1 (R1) 0.088 0.089 0.088 0.088 0.090
    Pivot Point 0.087 0.087 0.086 0.086 0.087
    Support 1 (S1) 0.083 0.085 0.083 0.083 0.080
    Support 2 (S2) 0.082 0.084 0.081 0.079
    Support 3 (S3) 0.078 0.082 0.079
    Support 4 (S4) 0.078